Earnings Ahead

ABT - Abbott

127.86 0.47 0.37

Abbott

Abbott

About

Profile

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to


Headquarters

Chicago, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ABT



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Abbott Q2 results top consensus as base business offsets COVID impact
  • Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
  • Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • Goldman Sachs sees rays of hope in underperforming health sector
  • BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
  • FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Abbott gains expanded coverage for glucose monitoring device in France
  • Abbott names Philip Boudreau CFO effective Sept. 1
  • Abbott Laboratories declares $0.51 dividend
  • Abbott alleges former scientist in its nutrition unit stole trade secrets
  • Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
  • Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
  • Abbott boasts of heart failure reduction data for CardioMEMS device
  • Abbott, other baby-formula makers see FTC probe over collusion - report
  • Abbott recalled baby formula claims tossed by federal judge
  • Abbott gains approval of TactiFlex ablation catheter treatment
  • Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
Date Price Open High Low Vol Change
Jan 23 123.22 118.13
123.22
118.17
11.3M 4.62%
Jan 22 117.78 114.13
119.94
113.5
13.2M 0.85%
Jan 21 116.79 114.25
116.9
114.14
8.5M 2.92%
Jan 17 113.48 113.62
114.79
113.39
6.5M -0.38%
Jan 16 113.91 111.02
113.95
111.02
5.6M 2.53%
 
Jan 15 111.1 112.15
112.76
110.86
6.5M -1.7%
Jan 14 113.02 113.56
113.81
112.29
4.0M -0.15%
Jan 13 113.19 112.6
113.39
111.98
4.4M 0.78%
Jan 10 112.31 113.77
113.84
111.79
5.1M -1.7%
Jan 8 114.25 113.54
114.31
112.26
4.5M 0.75%
Jan 7 113.4 113.37
114.69
113.17
5.3M 0.32%
Jan 6 113.04 113.51
114.26
112.79
6.0M -0.69%
Jan 3 113.83 113.94
114.23
113.28
4.4M 0.34%
Jan 2 113.44 113.69
113.96
112.75
3.6M 0.29%
Dec 31, 2024 113.11 113.06
113.78
112.54
3.5M 0.27%
Dec 30, 2024 112.8 114.13
114.64
112.52
3.5M -1.9%
Dec 27, 2024 114.99 115.01
115.95
114.51
2.8M -0.24%
Dec 26, 2024 115.27 114.2
115.81
113.82
3.0M 0.44%
Dec 24, 2024 114.76 114.14
114.83
113.59
1.5M 0.39%
Dec 23, 2024 114.31 114
114.51
112.96
4.0M 0.07%
Dec 20, 2024 114.23 112.64
115.11
112.52
12.3M 1.61%
Dec 19, 2024 112.42 111.54
113.29
111.28
7.7M 0.44%
Dec 18, 2024 111.93 113.03
114.15
111.85
6.5M -1.2%
Dec 17, 2024 113.29 112.21
113.84
112.2
5.8M 0.59%
Dec 16, 2024 112.62 112.7
113.65
112.39
5.0M -0.67%
Dec 13, 2024 113.38 113.85
114.29
112.14
4.6M -0.42%
Dec 12, 2024 113.86 114.4
114.78
113.3
3.8M -0.25%
Dec 11, 2024 114.14 115.31
115.58
114.01
4.7M -1.18%
Dec 10, 2024 115.5 115.08
116.39
114.27
4.1M 0.52%
Dec 9, 2024 114.9 115.67
115.87
113.85
4.9M -0.61%
Dec 6, 2024 115.6 115.13
116.2
115.1
5.3M 0.01%
Dec 5, 2024 115.59 115.26
116.29
114.89
3.3M -0.33%
Dec 4, 2024 115.97 117.01
117.01
115.29
3.6M -0.28%
Dec 3, 2024 116.29 117.1
117.44
116.07
4.8M -0.45%
Dec 2, 2024 116.81 118.75
118.81
116.59
5.3M -1.65%
Nov 29, 2024 118.77 118.71
119.19
117.86
2.5M -0.15%
Nov 27, 2024 118.95 118.35
120.53
118.1
3.5M 0.84%
Nov 26, 2024 117.96 118.64
119
117.01
4.1M -0.14%
Nov 25, 2024 118.13 118.28
118.65
117.58
6.9M 0.31%
Nov 22, 2024 117.76 117.22
118
116.38
5.3M 0.43%
Nov 21, 2024 117.26 115.68
117.64
115.14
5.6M 1.15%
Nov 20, 2024 115.93 116.69
116.77
115.53
5.6M -1.02%
Nov 19, 2024 117.13 116.54
117.55
115.45
4.5M -0.2%
Nov 18, 2024 117.36 115.57
117.94
115.51
6.1M 1.26%
Nov 15, 2024 115.9 114.87
116.35
114.43
6.9M 0.76%
Nov 14, 2024 115.03 115.98
116.09
114.93
3.8M -0.61%
Nov 13, 2024 115.74 116.08
116.81
115.55
4.8M -0.6%
Nov 12, 2024 116.44 116.68
117.3
116.42
4.6M -0.31%
Nov 11, 2024 116.8 116.94
117.84
116.33
5.3M 0.18%
Nov 8, 2024 116.59 115.33
117.25
114.69
5.7M 1.12%
Nov 7, 2024 115.3 117.49
117.49
114.54
5.5M -1.28%
Nov 6, 2024 116.8 121
121
115.5
5.3M -0.79%
Nov 5, 2024 117.73 117.59
118.25
116.33
4.1M 0.07%
Nov 4, 2024 117.65 119.6
120.57
117.48
5.6M -0.8%
Nov 1, 2024 118.6 119.75
119.92
117.09
10.1M 4.61%
Oct 31, 2024 113.37 113.57
114.47
113.27
5.3M -0.94%
Oct 30, 2024 114.45 112.64
114.74
112.5
5.2M 0.93%
Oct 29, 2024 113.4 114.14
114.74
113.35
4.5M -0.59%
Oct 28, 2024 114.07 114.77
114.83
113.55
4.1M -0.13%
Oct 25, 2024 114.22 116.14
116.39
113.2
6.0M 0%